Opportunities for Early Identification: Implementing Universal Depression Screening with a Pathway to Suicide Risk Screening in a Pediatric Health Care System - 20/01/22
, Laika D. Aguinaldo, PhD 2, Chelsea Carter, MA 1, Glenn F. Billman, MD 1, Kendall Sanderson, MS 1, Cynthia Kuelbs, MD 1, 3Abstract |
Objectives |
To describe the implementation process and assess results of a large-scale universal depression screening program with pathways to suicide risk screening in a pediatric integrated delivery network.
Study design |
This retrospective study analyzes depression and suicide risk screening data for 95 613 patients ages 12-17 years.
Results |
Of the 95 613 adolescent patients who were screened for depression, 2.4% (2266) screened positive for risk for moderate-severe depression (>10 Patient Health Questionnaire; 9-item version) and 4.1% (3942) endorsed elevated suicide risk (≥1 Columbia Suicide Severity Rating Scale). Overall, 51% of screened patients who present with a primary psychiatric concern screened positive for elevated risk of suicide (2132). Two percent of screened patients who presented with a primary medical concern screened positive for elevated risk of suicide. Nearly one-half (45.9%) of all elevated suicide risk screenings were from patients with a primary medical concern.
Conclusions |
A large-scale universal depression screening program with a pathway to identify elevated suicide risk was implemented in a pediatric health care system using the Patient Health Questionnaire and the Columbia Suicide Severity Rating Scale. This screening program identified youth with moderate-severe depression and elevated risk for suicide with and without presenting psychiatric concerns across service settings.
Le texte complet de cet article est disponible en PDF.Keywords : prevention, implementation
Abbreviations : C-SSRS, ED, ICD, PHQ, PHQ-9, PHQ-2, RCHSD
Plan
| Supported by the National Institute on Drug Abuse grants U01 DA041089 (to L.A.). The content is solely the view of the authors and does not necessarily represent the official view of the National Institutes of Health. The authors declare no conflicts of interest. |
Vol 241
P. 29 - février 2022 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
